candidates are referred to the transplant center to begin the evaluation process.
The living donor evaluation is a complex multistep screening process that requires medical clearance, multiple interactions with the transplant center and sometimes even long distance travel. Thus, one potential source of racial disparities in LDKT could be delays during completion of the living donor evaluation process. Previous single-center studies have reported that AA donor candidates may have a lower likelihood of clinical suitability for donor nephrectomy. 4, 12 Additionally, AA donor candidates may be more likely to be deemed medically ineligible, 4, 12, 13 lost to follow-up, 14 and decide against donation. 12, 13 However, it is unclear if additional delays or barriers are experienced by AA donor candidates at specific steps of the living donor evaluation process.
To better understand the process following living donor candidate referral, and thereby gain potential insights into mechanisms underlying racial disparities in LDKT, we studied time to kidney donation for AA and non-AA donor candidates referred to our center.
We further studied the progression of the living donor candidates through each step of the evaluation process to identify delays.
| ME THODS

| Study population
We studied 911 living donor candidates that came forward on behalf of adult kidney transplant candidates at our center between January 2, 2011 and March 16, 2015. We used electronic medical records to obtain donor demographic information (age, sex, race, blood group, and body mass index) and donor candidate outcomes (date the donor candidate reached each step in the evaluation process, became ineligible, or donated). This study was approved by the Johns Hopkins University Institutional Review Board.
| Distance to transplant center
Distances between donor candidates and transplant centers were calculated with the latitude and longitude of the geographic centroid of the donor candidate ZIP code and the latitude and longitude of the transplant center ascertained by Google maps search.
ZIP code locations were obtained from the zipcode package available through R, which contains a database of latitudes and longitudes for US ZIP codes from the CivicSpace database (August 2004) and augmented with data from federalgovernmentzipcodes.
us (Jan 22, 2012). As previously described, 15 to account for the curve of the earth the distance in miles was calculated using an arc-distance equation with the latitudes and longitudes expressed in radians as:
Distance was categorized a priori to separate major metropolitan areas known to refer patients to our center (0-50 Baltimore, DC; 51-300 New York City, Philadelphia, Richmond; 301-1000 Raleigh, Atlanta, Orlando; >1000 Dallas, Los Angeles).
| Donor candidate socioeconomic status
We linked our donor candidate data to U.S. Census data using each donor candidate's ZIP code to estimate a socioeconomic status (SES) index. We used the Agency for Healthcare Research and Quality SES index with possible values standardized to range from 0 to 100. 14 A higher index value corresponds to higher SES and a lower index value corresponds to lower SES. 16 The index was calculated according to the formula:
| Living donor candidate evaluation process
At our center, the living donor candidate evaluation includes five key steps:
1. Donor referral and cross-match-Interested living donor candidates contact the transplant office or complete an online kidney donor questionnaire. Living donor candidates are then asked to obtain blood work for blood type confirmation and tissue typing.
2.
Medical screening-Living donor candidates undergo comprehensive testing such as 24 hours urine collection, urinalysis, blood work, a stool test for occult blood, Tuberculosis testing, current mammogram, and colonoscopy.
3. Evaluation-Donor candidates are seen by the nephrologist, surgeon, psychologist, social worker, and nurse coordinator during a one day visit and undergo diagnostic testing (3D CAT scan, EKG, Chest X-ray).
4.
Clearance-The transplant team meets to discuss the medical results weekly and deem donor candidates appropriate for surgery.
5.
Transplant-A date is scheduled for donation.
| Donor candidate acceptance criteria
At our center, potential donors must have a Body Mass Index (BMI)
under 35 kg/m 2 . Potential donors with hypertension that are considered for donation must be >50 years old, non-AA, and on one blood pressure medication or on less than the maximum dose of a combination pill.
| Outcome ascertainment for donor candidates
We evaluated time from donor candidate referral to donation, censoring for donor-related ineligibility, kidney transplant 
candidate-related ineligibility, and end of study date as censored observations. Administrative censorship, as used in the context of this study, provides the number of potential live donors that are still being evaluated in the process. Furthermore, we estimated time from donor candidate referral to medical screening, medical screening to evaluation, evaluation to clearance, and clearance to transplant by donor candidate race, censoring for the same events.
| Reasons for non-donation
The reasons for non-donation among donor candidates at our center were categorized as donor-related reasons (medical, financial, personal, social, or alternate donor candidate selected). For donor-related reasons of non-donation, financial, personal, and social were categorized as "other" in Table 3 and 
| Statistical analysis
We followed AA and non-AA living donor candidates through the evaluation process, from the date of referral to their end-point (donated, donor-related ineligibility, kidney transplant candidate-related ineligibility, or administratively censored) to investigate differences in the donor candidate experience by race. No Non-Directed Donors, Kidney Paired Exchange Donors, or ABO incompatible donors were included in the study. At the medical screening step, only one donor candidate is chosen to progress through the rest of the process.
We conducted a sensitivity analysis comparing characteristics and results of the first donor referred compared to subsequent donors referred on behalf of a kidney transplant candidate and found no differences. Thus, we restricted the analysis to the first donor candidate who came forward on behalf of a transplant candidate. For all models, we adjusted for donor candidate characteristics including race, sex, age, obesity (BMI > 30), donor-recipient relationship, and distance from the transplant center.
In a sensitivity analysis, we used a competing risks framework comparing the outcomes of medical ineligibility, reason for nondonation, and progression to the next step. 17 Similar results were obtained in the sensitivity analysis using competing risks regression and thus we chose to describe our results using cox regression. For all models, we administratively censored donor candidates on March 16, 2015. Confidence intervals are reported as per the method of Louis and Zeger. 18 All analyses were performed using Stata 14.0/MP for Linux (College Station, Texas).
| RE SULTS
| Living donor candidates
There were a total of 911 donor candidates referred to our center between January 2, 2011 and March 16, 2015, on behalf Bold-statistically significant P < .05.
| Living donor evaluation and clearance
The 1-year and 2-year cumulative incidence of donation was 14%
and 30%, respectively. The 1-year and 2-year cumulative incidence of donation among AA donor candidates was 8.0% and 20%, respectively, in comparison to, 17% and 36% for non-AA donor candidates ( Figure 1) . In an unadjusted analysis, AA donor candidates were less likely to progress from referral to donation (HR: 0.27 0.41 0.79 , P < .001). After adjustment for donor candidate characteristics, AA donor candidates remained less likely to progress from referral to donation (aHR: 0.26 0.47 0.83; P = .01, Table 2 ).
| Reasons for non-donation
Among 247 AA donor candidates, 46 (19%) were still in the process, 17 (7%) donated, and 184 (74%) did not donate (Table 3 ).
The transplant candidate-related reasons for non-donation were as follows: the transplant candidate received a deceased donor transplant (7%), was no longer a candidate (17%), received a transplant at another facility (3%), and other transplant candidate related issue (1%). The donor-related reasons for non-donation were medical (42%), social (10%), personal (16%), or other donor selected (4%). The top medical reasons for non-donation among AA donor candidates were hypertension (45%), obesity (32%), and kidney abnormalities (11%).
Among 664 non-AA donor candidates, 96 (14%) were still in the process, 83 (13%) donated, and 485 (73%) did not donate ( Table 3 ).
The transplant candidate-related reasons for non-donation were: the transplant candidate received a deceased donor transplant (11%), was no longer a candidate (16%), received a transplant at another facility (10%), and other transplant candidate related issue (3%). The donor-related reasons for non-donation were medical (26%), social (8%), personal (17%), or other donor selected (9%). The top medical reasons for non-donation among non-AA donor candidates were hypertension (26%), obesity (25%), and kidney abnormalities (25%).
Compared with non-AA donor candidates, AA donor candidates were more likely to be deemed medically ineligible for donation due to hypertension and obesity (HTN: 45% AA vs 26% non-AA, BMI:
32% AA vs 25% non-AA).
Overall, the reasons for non-donation differed during each step of the donor evaluation process. The reasons for non-donation during referral to medical screening (56% vs 44%), medical screening to evaluation (65% vs 35%), and evaluation to clearance (61% vs 39%)
were mostly due to donor-related reasons. Whereas, reasons for non-donation during cleared to donation (63% vs 37%) were mostly due to candidate-related reasons (Table 4) .
| Referral to medical screening
Upon further examination of each step in the donor evaluation process, the median time from referral to medical screening for those who actually donated was 2.2 months (2.5 months AA vs 2.2 months non-AA) (Figure 2 ). Among those who did not make it to the next step, the median time from referral to medical screening was 3.4 months (2.6 months AA vs 3.7 months non-AA). The median time for AA donor candidates compared with non-AA was similar (11.1 months vs 13.2 months; P = .6). After adjusting for donor characteristics, AA donor candidates were as likely to progress from referral to medical screening as non-AA donor candidates (aHR:
0.85 1.10 1.43, P = .5, Table 2 ).
| Medical screening to evaluation
The median time from medical screening to evaluation of those who actually donated was 2. (10) 17 (10) 39 (8) Medical 199 (29) 74 (42) 120 (26) HTN 63 (32) 42 (45) 34 (26) BMI 53 (26) 30 (32) 33 (25) Kidney abnormalities h 41 (21) 10 (11) 32 (25) Medical History 25 (13) 6 (7) 18 (14) Diabetes 11 (5) 5 (5) 5 (4) Other non-AA, Figure 2 ). Among those who did not make it to the next step, the median time from medical screening to evaluation was Table 2 ).
| Evaluation to clearance
From evaluation to clearance, the median time among those who actually donated was 1.0 month (1.2 months AA vs 0.9 months non-AA, Figure 2 ). Among those who did not make it to the next step, the median time from evaluation to clearance was 2.9 months (4.5 months AA vs 2.7 months non-AA). The median time for AA and non-AA donor candidates were similar (2.3 months vs 2.1 months; P = .7). Even after accounting for differences in donor characteristics, AA donor candidates were as likely to progress from evaluation to clearance as non-AA donor candidates (aHR: 0.59 0.93 1.44, P = .5, Table 2 ).
| Clearance to donation
The median time from clearance to transplant of those who actually donated was 2.7 months (1.4 months AA vs 1.0 months non-AA, Figure 2 ). Among those who did not make it to the next step, the median time from clearance to donation was 3.3 months (3.0 months AA vs 3.7 months non-AA). The median time for AA and non-AA donor candidates were similar (3.7 months vs 3.8 months; P = .4, Figure 3 ). After accounting for differences in donor characteristics, AA donor candidates were less likely to progress from clearance to (14) 3 (7) 4 ( donors that are still being evaluated in the process. b 2% were missing a reason for non-donation. c 37% were missing a reason for non-donation; this may be due to a lack of record updating during this step since majority of the donor candidates that did not proceed forward were due to donorrelated medical reasons. d Other related issue: candidate death, candidate moved, or do not know. e Social/Personal reasons includes donor candidate decided not to go forward in the process or transplant team decided against proceeding with the donor candidate due to social reasons. f Kidney abnormalities = anatomy, proteinuria, cysts, pyelonephritis, atrophic left kidney, urological history, polycystic disease, kidney Stones, insufficient kidney function (low GFR/creatinine clearance). g Other medical reason = pregnant, unknown, infectious disease.
TA B L E 4
Outcomes and reasons for non-donation among donor candidates referred by phase donation as non-AA donor candidates (aHR: 0.28 0.51 0.91, P = .02, Table 2 ).
| D ISCUSS I ON
In this single-center study of racial differences in living kidney donation, we followed 247 AA and 664 non-AA living donor candidates through the donor referral and evaluation process. Previous studies have reported that AA donor candidates were less likely to be recruited for donation, less likely to have converted from a donor candidate to a donor, less likely to donate, and more likely to decide against donation. 12, 13 Extending from this prior literature, the key strength of our study is that we were able to isolate the specific step in the donor evaluation process where the racial differences were most pronounced. We found that AA donor candidates had a longer median time from medical screening to evaluation and from clearance to donation compared to non-AA donor candidates. These findings offer a potential explanation for the previously reported disparities of AA donor candidates being less likely to convert to donors and less likely to donate overall. Current strategies to achieve growth in living donor kidney transplantation do not take this into consideration. 5, 10, [19] [20] [21] [22] [23] [24] [25] We hypothesized that the disparity in this specific step could be explained by the fact that AA nationally have a higher prevalence of hypertension, obesity, diabetes. 26 As such, our study was able to demonstrate that a substantial proportion of AA donor candidates were biologically related. Given well documented familial clustering of diabetes, hypertension, and chronic kidney disease, this heavy reliance on biological relatives might be a nontrivial driver of the observed disparities in access to live donor kidney transplantation. [2] [3] [4] [5] In addition, our study adjusted for donor candidate distance to transplant center given that time and distance of travel to the center may be a contributing factor to the rate of progression through the living donor evaluation process. 27 Unlike previous literature, we were able to demonstrate that a substantial proportion of AA donor candidates lived within 50 miles of our transplant facility. 28 Thus, delays may be a manifestation of the transplant candidate's social network; drawn predominantly from biological relatives, persons living in close proximity, and from persons who are likely to be deemed medically ineligible for live kidney donation. Targeted efforts to optimize networks for identification of donor candidates may help address LDKT disparities.
F I G U R E 2 Living donor candidate evaluation process. Among those who progressed to donation, the median time from referral to donation was 9.2 mo (10.2 mo AA vs 8.9 mo non-AA). Among those who made it to the next step, the median time from referral to medical screening was 2.2 mo (2.5 mo AA vs 2.2 mo non-AA), from medical screening to evaluation was 2.4 mo (2.8 mo AA vs 2.3 mo non-AA), from evaluation to clearance was 1.0 mo (1.2 mo AA vs 0.9 mo non-AA), and from clearance to transplant was 2.7 mo (1.4 mo AA vs 1.0 mo non-AA). Among those who were deemed ineligible, the median time from referral to donation was 4.3 mo (3.7 mo AA vs 4.6 mo non-AA).
Among those who did not make it to the next step, the median time from referral to medical screening was 3.4 mo (2.6 mo AA vs 3.7 mo non-AA), from medical screening to evaluation was 3.9 mo (5.3 mo AA vs 3.4 mo non-AA), from evaluation to clearance was 2.9 mo (4.5 mo AA vs 2.7 mo non-AA), and from clearance to transplant was 3.3 mo (3.0 mo AA vs 3.7 mo non-AA)
Our study provides insight on previously reported reasons for racial disparities in living kidney donation. Some studies have reported that AA donor candidates are often lost to follow-up during the evaluation process, which authors assume is a reflection of their willingness to donate. However, survival analytic methods were not used to reach these inferences and thus, the large proportion of AA donor candidates that were lost to follow-up might represent an artifact of the methods used. [12] [13] [14] Using survival analytic methods provides better estimates, as it separates the number of donor candidates still in the evaluation process from the number of donor candidates who are truly lost to follow-up. Our study found that 19%
of AA donor candidates were still in the process compared to 14% of non-AA donor candidates. Furthermore, the progression of a living kidney donor candidate through the evaluation process is inherently linked to the status of the transplant candidate (ie transplant candidate medical ineligibility, received a deceased donor transplant, transplant candidate death, moved, or transplantation at another center). Our methods were able to reveal whether the reasons for non-donation were predominantly donor-related or candidaterelated for each step of the process. The reasons for non-donation during referral to medical screening (56% donor vs 44% candidate), medical screening to evaluation (65% donor vs 35% candidate), and evaluation to clearance (61% donor vs 39% candidate) were mostly due to donor-related reasons. Whereas the reasons for nondonation from clearance to donation (63% candidate vs 37% donor)
were mostly transplant candidate-related. Further studies should investigate and optimize the donor candidates lost due to candidaterelated reasons.
The living donor evaluation process is not standardized across the U.S. and thus our exact evaluation process may not be generalizable to other centers. [12] [13] [14] [29] [30] [31] However, our analytic approach was able to reveal the key features and complexities of the donor evaluation process at our center, which can be used at other transplant centers to identify barriers in their specific process. Our study does reveal the specific steps in the process where the racial disparity is greatest. Additionally, we provide our centers donor acceptance criteria as context for other transplant centers. As such, it is likely that our inferences are relevant to transplant centers nationwide. This information could be incorporated into future studies to better understand barriers at this step and for interventions that are designed towards increasing living donation. 5, 10, 11, 24, 32, 33 In conclusion, AA donor candidates experienced delays during the evaluation process following referral. AA donor candidates were less likely to progress through living donor evaluation process, F I G U R E 3 Time through the living donor evaluation process for donor candidates referred on behalf of a kidney transplant candidate by race and phase
